We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+5.56%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$14.4B
AUM Growth
+$580M
Cap. Flow
-$102M
Cap. Flow %
-0.7%
Top 10 Hldgs %
30.89%
Holding
368
New
16
Increased
155
Reduced
158
Closed
9

Top Buys

Rank Stock Value
1
ADP icon
Automatic Data Processing
ADP
+$64.6M
2
LLY icon
Eli Lilly
LLY
+$31.3M
3
MDLZ icon
Mondelez International
MDLZ
+$25.7M
4
AVGO icon
Broadcom
AVGO
+$21.7M
5
PSX icon
Phillips 66
PSX
+$11.8M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.1M
2
HPQ icon
HP
HPQ
+$40M
3
NEE icon
NextEra Energy
NEE
+$33M
4
PAYX icon
Paychex
PAYX
+$25.1M
5
CSCO icon
Cisco
CSCO
+$19.9M

Sector Composition

Rank Sector Weight
1 Technology 19.25%
2 Financials 16.25%
3 Healthcare 12.13%
4 Consumer Staples 10.11%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VEA icon
326
Vanguard FTSE Developed Markets ETF
VEA
$236B
$308K ﹤0.01%
6,982
-585
-8% -$24.9K
HIW icon
327
Highwoods Properties
HIW
$3.51B
$293K ﹤0.01%
6,000
FLIR
328
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
$282K ﹤0.01%
5,422
-284
-5% -$15K
EEM icon
329
iShares MSCI Emerging Markets ETF
EEM
$29.4B
$273K ﹤0.01%
6,081
+35
+0.6% +$1.5K
DG icon
330
Dollar General
DG
$28B
$271K ﹤0.01%
1,739
+148
+9% +$23.5K
SLB icon
331
SLB Ltd
SLB
$76.4B
$263K ﹤0.01%
6,554
+356
+6% +$12.7K
YUM icon
332
Yum! Brands
YUM
$41.3B
$260K ﹤0.01%
2,577
VSS icon
333
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$11.8B
$254K ﹤0.01%
2,284
VTR icon
334
Ventas
VTR
$47.7B
$237K ﹤0.01%
4,100
-2,030
-33% -$127K
CHKP icon
335
Check Point Software Technologies
CHKP
$12.9B
$233K ﹤0.01%
2,100
AMAT icon
336
Applied Materials
AMAT
$426B
$226K ﹤0.01%
+3,700
New +$208K
CNI icon
337
Canadian National Railway
CNI
$76.6B
$225K ﹤0.01%
2,486
+104
+4% +$9.35K
TEL icon
338
TE Connectivity
TEL
$62.2B
$222K ﹤0.01%
+2,312
New +$214K
TROW icon
339
T. Rowe Price
TROW
$24.1B
$221K ﹤0.01%
+1,816
New +$214K
MAR icon
340
Marriott International
MAR
$93.2B
$217K ﹤0.01%
1,430
-339
-19% -$45.4K
EPD icon
341
Enterprise Products Partners
EPD
$82.4B
$215K ﹤0.01%
7,644
-2,350
-24% -$63.7K
ELV icon
342
Elevance Health
ELV
$84.9B
$213K ﹤0.01%
+704
New +$194K
FTV icon
343
Fortive
FTV
$18.6B
$212K ﹤0.01%
+4,393
New +$198K
BNS icon
344
Scotiabank
BNS
$108B
$211K ﹤0.01%
3,734
-566
-13% -$32.2K
FBIN icon
345
Fortune Brands Innovations
FBIN
$6.07B
$211K ﹤0.01%
+3,783
New +$199K
BF.A icon
346
Brown-Forman Class A
BF.A
$13.2B
$208K ﹤0.01%
+3,318
New +$204K
LCNB icon
347
LCNB Corp
LCNB
$282M
$208K ﹤0.01%
10,800
AWK icon
348
American Water Works
AWK
$26.9B
$205K ﹤0.01%
+1,665
New +$202K
GS icon
349
Goldman Sachs
GS
$303B
$205K ﹤0.01%
+892
New +$194K
ADBE icon
350
Adobe
ADBE
$106B
$204K ﹤0.01%
+618
New +$182K

Similar funds

Bahl & Gaynor's Q4 2019 Portfolio in Review

As of Q4 2019, Bahl & Gaynor held 368 positions worth $14.4B, up 4.2% from $13.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2019 filing shows 16 new, 155 increased, 158 reduced and 9 closed positions. Its largest new stake was Penske Automotive Group: 54,533 shares worth $2.74M. The largest sale was Pfizer, an estimated $45.1M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Bahl & Gaynor's largest Q4 2019 buy was Penske Automotive Group: 54,533 shares worth $2.74M.
  • Bahl & Gaynor added most to Automatic Data Processing in Q4 2019, an estimated $64.6M increase.
  • Bahl & Gaynor's biggest Q4 2019 reduction was Pfizer, cutting an estimated $45.1M.
  • Bahl & Gaynor fully exited KLA in Q4 2019, selling an estimated $3.18M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $14.4B portfolio in Q4 2019.
  • Bahl & Gaynor opened 16 new positions and closed 9 in Q4 2019.
  • Bahl & Gaynor's portfolio value rose 4.2% quarter-over-quarter to $14.4B.

Based on Bahl & Gaynor's 13F filing for Q4 2019, filed 14 Feb 2020.